317 related articles for article (PubMed ID: 2821180)
1. Identification of sequences in Epstein-Barr virus DNA required for the expression of the second Epstein-Barr virus-determined nuclear antigen in COS-1 cells.
Ricksten A; Svensson C; Welinder C; Rymo L
J Gen Virol; 1987 Sep; 68 ( Pt 9)():2407-18. PubMed ID: 2821180
[TBL] [Abstract][Full Text] [Related]
2. Expression of a second Epstein-Barr virus-determined nuclear antigen in mouse cells after gene transfer with a cloned fragment of the viral genome.
Rymo L; Klein G; Ricksten A
Proc Natl Acad Sci U S A; 1985 May; 82(10):3435-9. PubMed ID: 2987926
[TBL] [Abstract][Full Text] [Related]
3. Viral and cellular factors influence the activity of the Epstein-Barr virus BCR2 and BWR1 promoters in cells of different phenotype.
Nilsson T; Sjöblom A; Masucci MG; Rymo L
Virology; 1993 Apr; 193(2):774-85. PubMed ID: 8384755
[TBL] [Abstract][Full Text] [Related]
4. Mapping genetic elements of Epstein-Barr virus that facilitate extrachromosomal persistence of Epstein-Barr virus-derived plasmids in human cells.
Lupton S; Levine AJ
Mol Cell Biol; 1985 Oct; 5(10):2533-42. PubMed ID: 3016506
[TBL] [Abstract][Full Text] [Related]
5. The 5' flanking region of the gene for the Epstein-Barr virus-encoded nuclear antigen 2 contains a cell type specific cis-acting regulatory element that activates transcription in transfected B-cells.
Ricksten A; Olsson A; Andersson T; Rymo L
Nucleic Acids Res; 1988 Sep; 16(17):8391-410. PubMed ID: 2843816
[TBL] [Abstract][Full Text] [Related]
6. Stable transfection of Epstein-Barr virus (EBV) nuclear antigen 2 in lymphoma cells containing the EBV P3HR1 genome induces expression of B-cell activation molecules CD21 and CD23.
Cordier M; Calender A; Billaud M; Zimber U; Rousselet G; Pavlish O; Banchereau J; Tursz T; Bornkamm G; Lenoir GM
J Virol; 1990 Mar; 64(3):1002-13. PubMed ID: 2154588
[TBL] [Abstract][Full Text] [Related]
7. Epstein-Barr virus nuclear antigen 2 transactivates the long terminal repeat of human immunodeficiency virus type 1.
Scala G; Quinto I; Ruocco MR; Mallardo M; Ambrosino C; Squitieri B; Tassone P; Venuta S
J Virol; 1993 May; 67(5):2853-61. PubMed ID: 8386279
[TBL] [Abstract][Full Text] [Related]
8. Expression of the Epstein-Barr virus nuclear protein 2 in rodent cells.
Dambaugh T; Wang F; Hennessy K; Woodland E; Rickinson A; Kieff E
J Virol; 1986 Aug; 59(2):453-62. PubMed ID: 2426468
[TBL] [Abstract][Full Text] [Related]
9. Integration of a short Epstein-Barr virus DNA fragment in a B95-8 virus converted Burkitt lymphoma line expressing Epstein-Barr nuclear antigens EBNA2 and EBNA5.
Trivedi P; Cuomo L; de Campos-Lima PO; Imreh MP; Kvarnung K; Klein G; Masucci MG
J Gen Virol; 1993 Jul; 74 ( Pt 7)():1393-8. PubMed ID: 8393080
[TBL] [Abstract][Full Text] [Related]
10. Expression in COS-1 cells of Epstein-Barr virus nuclear antigen from a complete gene and a deleted gene.
Robert MF; Shedd D; Weigel RJ; Fischer DK; Miller G
J Virol; 1984 Jun; 50(3):822-31. PubMed ID: 6328012
[TBL] [Abstract][Full Text] [Related]
11. Characterization of a second Epstein-Barr virus-determined nuclear antigen associated with the BamHI WYH region of EBV DNA.
Dillner J; Kallin B; Ehlin-Henriksson B; Timar L; Klein G
Int J Cancer; 1985 Mar; 35(3):359-66. PubMed ID: 2982749
[TBL] [Abstract][Full Text] [Related]
12. Stable transfection of a human lymphoma line by sub-genomic fragments of Epstein-Barr virus DNA to measure humoral and cellular immunity to the corresponding proteins.
Welinder C; Larsson NG; Szigeti R; Ehlin-Henriksson B; Henle G; Henle W; Klein G; Ricksten A; Rymo L; Sulitzeanu D
Int J Cancer; 1987 Sep; 40(3):389-95. PubMed ID: 3040603
[TBL] [Abstract][Full Text] [Related]
13. U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2.
Dambaugh T; Hennessy K; Chamnankit L; Kieff E
Proc Natl Acad Sci U S A; 1984 Dec; 81(23):7632-6. PubMed ID: 6209719
[TBL] [Abstract][Full Text] [Related]
14. Epstein-Barr virus nuclear antigen 2 (EBNA2)-oestrogen receptor fusion proteins complement the EBNA2-deficient Epstein-Barr virus strain P3HR1 in transformation of primary B cells but suppress growth of human B cell lymphoma lines.
Kempkes B; Zimber-Strobl U; Eissner G; Pawlita M; Falk M; Hammerschmidt W; Bornkamm GW
J Gen Virol; 1996 Feb; 77 ( Pt 2 )():227-37. PubMed ID: 8627226
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear antigen 2 induces expression of the virus-encoded latent membrane protein.
Abbot SD; Rowe M; Cadwallader K; Ricksten A; Gordon J; Wang F; Rymo L; Rickinson AB
J Virol; 1990 May; 64(5):2126-34. PubMed ID: 2157875
[TBL] [Abstract][Full Text] [Related]
16. Transient expression of the Epstein-Barr virus LMP1 gene in human primary B cells induces cellular activation and DNA synthesis.
Peng M; Lundgren E
Oncogene; 1992 Sep; 7(9):1775-82. PubMed ID: 1354347
[TBL] [Abstract][Full Text] [Related]
17. Methylation status of the Epstein-Barr virus (EBV) BamHI W latent cycle promoter and promoter activity: analysis with novel EBV-positive Burkitt and lymphoblastoid cell lines.
Hutchings IA; Tierney RJ; Kelly GL; Stylianou J; Rickinson AB; Bell AI
J Virol; 2006 Nov; 80(21):10700-11. PubMed ID: 16920819
[TBL] [Abstract][Full Text] [Related]
18. An Epstein-Barr virus (EBV)-determined nuclear antigen (EBNA5) partly encoded by the transformation-associated Bam WYH region of EBV DNA: preferential expression in lymphoblastoid cell lines.
Dillner J; Kallin B; Alexander H; Ernberg I; Uno M; Ono Y; Klein G; Lerner RA
Proc Natl Acad Sci U S A; 1986 Sep; 83(17):6641-5. PubMed ID: 3018741
[TBL] [Abstract][Full Text] [Related]
19. Domains of the Epstein-Barr virus nuclear antigen 2 (EBNA2) involved in the transactivation of the latent membrane protein 1 and the EBNA Cp promoters.
Sjöblom A; Nerstedt A; Jansson A; Rymo L
J Gen Virol; 1995 Nov; 76 ( Pt 11)():2669-78. PubMed ID: 7595374
[TBL] [Abstract][Full Text] [Related]
20. Deletion mutants that affect expression of Epstein-Barr virus nuclear antigen in COS-1 cells after gene transfer with simian virus 40 vectors containing portions of the BamHI K fragment.
Polvino-Bodnar M; Shedd D; Miller G
J Virol; 1986 May; 58(2):324-30. PubMed ID: 3009849
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
